Sarina Janssens Farma SRL
Sarina Janssens Farma reported total assets of 136,654 € at the end of the 2025 financial year (annual accounts filed with the NBB on 07 Apr 2026).
The score of Sarina Janssens Farma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +153 % Total assets +46 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sarina Janssens Farma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Apr 2026
- Year ended 31 Dec 2024filed on 11 Jun 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
Sarina Janssens Farma's financial analysis
- Solvency69.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sarina Janssens Farma
Sarina Janssens Farma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0791.783.977
- VAT number
- BE0791783977
- Peppol
- Registered · 0208:0791783977 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Oct 2022
- Registered office
- 3360 Bierbeek
- Latest accounts
- 2025 · filed on 07 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sarina Janssens Farma (SRL) has been based in Bierbeek since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 28,598 € and equity of 95,107 €; its revenue is not published. Its solvency stands at 69.6%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sarina Janssens Farma
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Karbon Plus Retail sale of pharmaceutical products Diksmuide · balance sheet 127,790 €
- Apocurae Retail sale of pharmaceutical products Kortemark · balance sheet 124,948 €
- BSB Pharma Retail sale of pharmaceutical products Berchem-Sainte-Agathe · balance sheet 118,927 €
- Curasan Retail sale of pharmaceutical products Zwalm · balance sheet 103,974 €
- Panax Retail sale of pharmaceutical products Wemmel · balance sheet 99,320 €
- White-to-Black Retail sale of pharmaceutical products Dilbeek · balance sheet 209,334 €
- Kato van Vooren Retail sale of pharmaceutical products Dendermonde · balance sheet 88,886 €
Frequently asked questions about Sarina Janssens Farma
What is the revenue of Sarina Janssens Farma?
Sarina Janssens Farma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sarina Janssens Farma?
In Belgium, the VAT number is the company number prefixed with BE: BE0791783977 for Sarina Janssens Farma, if the company is VAT-registered. Its company number (CBE) is 0791.783.977.
Where is the registered office of Sarina Janssens Farma?
According to the CBE register, the registered office of Sarina Janssens Farma is in 3360 Bierbeek.
What is the equity of Sarina Janssens Farma?
At the close of the 2025 financial year, the equity of Sarina Janssens Farma amounts to 95,107 €, a solvency of 69.6% of total assets.
Who manages Sarina Janssens Farma?
The register lists 1 active mandates at Sarina Janssens Farma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sarina Janssens Farma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →